Top

Published in:

01-09-2005

Prevalence of Prothrombotic Abnormalities in Patients with Acute Mesenteric Ischemia

Authors: Nazım Ağaoğlu, M.D., Serdar Türkyılmaz, M.D., Ercüment Ovalı, M.D., Fahri Uçar, M.D., Celal Ağaoğlu, M.D.

Published in: World Journal of Surgery | Issue 9/2005

Abstract

Acute mesenteric ischemia (AMI) is a rare condition that may be associated with a variety of congenital prothrombotic disorders (PDs). The purpose of this study was to assess the prevalence of these disorders in 28 AMI patients compared with 103 healthy individuals from the northeastern region of Turkey. They were screened for protein C, antithrombin III, and protein S deficiencies; and gene analysis was performed using the polymerase chain reaction. A PD was revealed in 16 (57%) patients and 33 (32%) controls (p = 0.020). Factor V Leiden (FVL), prothrombin G20210A mutation, and TT677 homozygous mutation of methylenetetrahydrofolate reductase was detected in 10 (36%) patients versus 16 (15%) controls (p = 0.035), 3 (11%) patients versus 10 (9%) controls (p = 1.00), and 1 (3%) patient versus no controls, respectively. Consistent with caucasian ethnic groups, there was high prevalence of PDs, especially FVL; and these abnormalities might be a significant predisposing factor in the pathogenesis of AMI.

Markis M, Rosendaal FR, Preston FE. Familial thrombophilia: genetic risk and management. J. Intern. Med. Suppl. 1997;740:9–15PubMed

Margaglione M, D’Andrea G, d’Addedda M, et al. The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation. Thromb. Haemost. 1998;79:907–911PubMed

AğaoğLu N, Türkyılmaz S, Arslan MK. Prothrombotic disorders in patients with mesenteric vein thrombosis. J. Invest. Surg. 2003;16:299–304PubMed

Gurgey A, Haznedaroğlu IC, Agesel T, et al. Two common genetic thrombotic risk factors: factor V Leiden and prothrombin G20210A in adult Turkisk patients with thrombosis. Am. J. Hematol. 2001;67:107–111CrossRefPubMed

Akar N, Akar E, Dalgin G, et al. Frequency of factor V 1691 G-A mutation in Turkish population. Thromb. Haemost. 1997;78:1527–1529PubMed

Akar N, Misirlioğlu M, Akar E, et al. Prothrombin gene 20210 G: a mutation in Turkish population. Am. J. Hematol. 1998;58:249CrossRef

Miller SA, Dykes DD, Polesky HF. A simple salting out procedure of extracting DNA from human nucleated cells. Nucleic Acids Res 1998;16:1215

Rosendaal FR. Risk factors for venous thrombosis: prevalence, risk, and interaction. Semin. Hematol. 1997;34:171–187PubMed

Shen MC, Lin JS, Tsay W. High prevalence of antithrombin III, protein C and protein S deficiency, but no factor V Leiden mutation in venous thrombophilic Chinese patients in Taiwan. Thromb.Res.1997;87:377–385CrossRefPubMed

10.

Lin JS, Shen NC, Tsay W. The mutation at position 20210 in the 3′-untranslated region of the prothrombin gone is extremely rare in Taiwanese Chinese patients with venous thrombophilia. Thromb. Haemost. 1998;80:343PubMed

11.

Rees DC, Cox M, Clegg JB. World distribution of FV Leiden. Lancet 1995;346:1133–1134CrossRefPubMed

12.

Ridker PM, Miletich JP, Hennekens CH, et al. Ethnic distribution of FV Leiden in 4047 men and women. J.A.M.A. 1997;277:1305–1130PubMed

13.

Cattaneo M, Chantatangkul V, Taioli E. The G20210: a mutation of the prothrombin gene in patients with previous first episodes of deep vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase TT677 and plasma prothrombin levels. Thromb. Res. 1999;93:1–8CrossRefPubMed

14.

Gómez RR, Cuesta M, García M. Prevalence of the FV Leiden mutation in the Spanish population [abstract] Thromb. Haemost. 1997;77:224

15.

Rosendaal FR, Doggen CJ, Zivelin A. Geographic distribution of the 20210 G to A prothrombin variant. Thromb. Haemost. 1998;79:706–708PubMed

16.

Souto JC, Coll I, Llobe D, et al. The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish population. Thromb. Haemost. 1998;80:306–309

17.

Genoud V, Castrion M, Annichino-Bizzacchi J, et al. Prevalence of three prothrombotic polymorphisms factor V G1691A, factor II G20210A and methylenetetrahydrofolate reductase (MTHFR) C 677T in Argentina. Thromb. Res. 2000;100:127–131CrossRefPubMed

18.

Ma J, Stampfer MJ, Hennekens CH, et al. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in U.S. physicians. Circulation 1996;94:2410–2416PubMed

19.

Jacques PF, Bostom AG, William RR, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996;3:7–9

20.

Maurizio M, Giovanna DA, Marina DA, et al. The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the factor V Leiden and the prothrombin A20210 mutation. Thromb. Haemost. 1998;79:907–911PubMed

21.

Rintelen C, Pabinger I, Leckner K, et al. No evidence for an increase of the risk of venous thrombosis in patients with factor V Leiden by the homozygous mutation in the methylenetetrahydrofolate gene. Blood Coagul Fibrinolysis 1999;10: 101–105

22.

Morita H, Taguchi J, Kurihara H, et al. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation 1997;95:2032–2036PubMed

23.

Motti C, Gnasso A, Bernardini S. Common mutation of methylenetetrahydrofolate reductase; correlation with homocysteine and other risk factors for vascular disease. Atherosclerosis 1998;139:377–383CrossRefPubMed

24.

Camacho Vanegas O, Giusti B, Restropo Fernandez CM, et al. Frequency of factor V (FV) Leiden and C677T methylenetetrahydrofolate reductase (MTHFR) mutations in Colombians. Thromb. Haemost. 1998;79:883–884PubMed

Title: Prevalence of Prothrombotic Abnormalities in Patients with Acute Mesenteric Ischemia
Authors: Nazım Ağaoğlu, M.D.
Serdar Türkyılmaz, M.D.
Ercüment Ovalı, M.D.
Fahri Uçar, M.D.
Celal Ağaoğlu, M.D.
Publication date: 01-09-2005
Publisher: Springer-Verlag
Published in: World Journal of Surgery / Issue 9/2005
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-005-7692-5

At a glance: The STEP trials

Springer Medicine

Prevalence of Prothrombotic Abnormalities in Patients with Acute Mesenteric Ischemia

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 9/2005

Invited Commentary

Prevalence of Thyroid Nodules and Carcinomas in Patients Operated on for Renal Hyperparathyroidism: Experience with 339 Consecutive Patients and Review of the Literature

When Is Curative Gastrectomy Justified for Gastric Cancer with Positive Peritoneal Lavage Cytology but Negative Macroscopic Peritoneal Implant?

Detection of Lymph Node Micrometastases and Isolated Tumor Cells in Sentinel and Nonsentinel Lymph Nodes of Colon Cancer Patients

Do Germans Keep Patients Too Long in Hospital? A Prospective Randomized Trial

Abdominal Angina in Patients with a Midgut Carcinoid, a Sign of Severe Pathology